Patient Registry for Berinert®, a C1-Esterase Inhibitor
Phase of Trial: Phase IV
Latest Information Update: 04 Oct 2016
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Hereditary angioedema
- Focus Adverse reactions
- Sponsors CSL Behring
- 04 Oct 2016 Results from older adult (aged >/=65 years) population (n=27) published in the Drugs and Aging.
- 17 Mar 2016 New trial record
- 07 Mar 2016 Results of 27 elderly subjects were presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology.